Tarik Benidir, MD : Research

This is a Phase 2, Multi-Arm, Multi-Cohort, Open-Label Study to Evaluate the Safety and Efficacy of Cretostimogene Grenadenorepvec in Participants with High-Risk Non-Muscle-Invasive Bladder Cancer.

Investigators

Padraic O'Malley, Tarik Benidir

Status

Accepting Candidates

Ages

18 Years - N/A

Sexes

All

The goal of this study is to conduct the first randomized-controlled trial to determine the oncologic efficacy of lymph node dissection in participants with upper tract urothelial cell carcinoma. The main questions it aims to answer are: To…

Investigator

Tarik Benidir

Status

Accepting Candidates

Ages

19 Years - N/A

Sexes

All

This study will investigate the efficacy of focal high intensity focused ultrasound (HIFU) in patients with localized radiorecurrent prostate cancer. This study will also investigate the change in participant quality of life after HIFU therapy as…

Investigator

Tarik Benidir

Status

Accepting Candidates

Ages

18 Years - N/A

Sexes

Male